33 results about "Renal patient" patented technology

The present invention relates to kits for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism. The kit provides means to measure the level of a PTH agonist and a PTH antagonist in a patient, and it further provides means for administering a PTH suppressing therapeutic to the patient so as to reduce the level of a PTH agonist and minimize the level of parathyroid hormone antagonist.

A medical monitoring device for monitoring electrical signals from the body of a subject is described. The medical monitoring device monitors electrical signals originating from a cardiac cycle of the subject and associates each cardiac cycle with a time index. The medical monitoring device applies a forward computational procedure to generate a risk score indicative of hyperkalemia, hypokalemia or arrhythmia of the subject. The medical monitoring device can adjust the forward computational procedure based upon clinical data obtained from the subject.

The invention provides methods for treatment of bacterial infections in impaired renal patients. Methods of the invention include administration of a therapeutically effective dose of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue.

The invention provides methods and compositions for treatment of bacterial infections. The composition may be a combination of factors, which include A0, A1, B1, B2, C0, C1, isoB0, and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimens include multiple dose administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. Dosing regimens for renal patients are also included.

The invention discloses low-protein noodles and a making method thereof. The low-protein noodles comprise raw materials of 0-30 parts of wheat flour, 30-100 parts of edible starch, 0-30 parts of modified starch, 0-15 parts of konjac powder, 0.1-0.4 part of propylene glycol alginate, 0.1-0.3 part of sodium carbonate, 0.1-0.2 part of sodium polyacrylate, 0.05-0.08 part of sodium pyrophosphate, 0.02-0.05 part of sodium tripolyphosphate and 0.1-0.3 part of calcium carbonate. The protein content of the low-protein noodles is lower than 3g / 100g, based on the condition that patients suffering from achronic kidney disease take in 300 g of the low-protein noodles every day, enough calorie is guaranteed, besides, the intake of non-superior protein every day is smaller than 9g, enough space is provided for the intake of high-quality protein, and the nutrition structure of the patients suffering from the chronic kidney disease is comprehensively balanced. Besides, the low-protein noodles are similar to ordinary noodles in mouth feel, so that the compliance of the patients is greatly improved, the patients can insist on eating the low-protein noodles for a long term easily, and the low-proteinnoodles are an ideal staple food for the patients suffering from the chronic kidney disease.

The invention is a method of detecting CAD in a CKD diagnosed human patient or CKD in a diagnosed CAD patient, or detection the presence of both CDK and CAD by assaying a plasma or serum sample of a human patient for elevated levels of BMP-4.

A use includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The use may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.

The present invention relates to compositions and methods for treating the nutritional deficiencies observed in patients suffering from renal disease and associated disorders. Specifically, the method involves administering to a renal patient a composition comprising vitamin C, vitamin E, B-complex vitamins, selenium, and zinc.

The invention provides methods and compositions for treatment of bacterial infections. The composition may be a combination of factors, which include A0, A1, B1, B2, CO, C1, isoB0, and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of abacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimens include multiple dose administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. Dosing regimens for renal patients are also included.

An object of the present invention is to provide a pharmaceutical agent which is administered to a patient with chronic kidney disease in which the progress of worsening of renal function is rapid whereby the progress of the symptom is suppressed or improved.The present invention relates to a progress-suppressing or improving agent for chronic kidney disease containing 5-hydroxy-1-methylhydantoin as an active ingredient. The pharmaceutical agent of the present invention showed a significant effect in a patient with chronic kidney disease where progress of the renal function decrease is rapid. The present pharmaceutical agent is very useful as a highly safe pharmaceutical agent which suppresses or improves the progress of worsening of the renal function of a patient with rapidly progressive chronic kidney disease for which there has been no effective therapeutic agent being simply and easily ingestible.

The invention relates to the technical field of drinking water filtration, and discloses a drinking water filtering device for nephrology patients. Including the body, the body is provided with a purification and filtration structure, the purification and filtration structure is located at the upper end of the body, the body is provided with a disinfection treatment structure, the disinfection treatment structure is located at the lower end of the body, and the body is provided with a water outlet structure, and the water outlet structure is located at the disinfection treatment structure side. Remove the heavy metal elements in drinking water and soften the water quality through the purification and filtration structure, disinfect the drinking water through the disinfection treatment structure to remove microorganisms in the drinking water, and temporarily store and release the treated drinking water through the water outlet structure, so that the kidneys When sick patients drink the treated water, the burden on their kidneys is reduced to ensure the treatment of the patients and avoid the aggravation of the patients' condition.

The invention discloses a lifting and decompressing device for scrotal edema of patients with kidney disease, which relates to the technical field of maintenance of kidney patients, and includes a binding belt and a second connecting belt, and installation blocks are installed on both sides corresponding to the binding belt , the insides of the two installation blocks are provided with inner installation grooves, and the inside of the inner installation grooves is rotatably connected with a locking gear, and one side of the locking gear is installed with a wire harness winding disc. The lifting decompression device for scrotal edema, by using the lifting device with a locking structure, can wrap the lower pocket belt around the outside of the scrotum, and put the first connecting belt and the second connecting belt on the penis, and use the connecting harness Lifting the scrotum can effectively reduce the pressure of the testicles on the scrotum, and at the same time, the lifting height of the lower belt can be adjusted by using the locking structure that can rotate in one direction, so that it can be better suitable for different patients and increase Suitability for patients.